HVEM Promotes the Osteogenesis of allo-MSCs by Inhibiting the Secretion of IL-17 and IFN-g in Vg4T Cells
HVEM Promotes the Osteogenesis of allo-MSCs by Inhibiting the Secretion of IL-17 and IFN-g in Vg4T Cells
复制标题
HVEM通过抑制Vg4T细胞中IL-17和IFN-g的分泌促进同种异体间充质干细胞的成骨
作者:
何磊;肖军;宋磊;周锐;荣志刚;贺伟峰;代飞
Bone defects are a common orthopaedic concern, and an increasing number of tissueengineered bones (TEBs) are used to repair bone defects. Allogeneic mesenchymal stem.cells (allo-MSCs) are used as seed cells in many approaches to develop TEB constructs,.but the immune response caused by allogeneic transplantation may lead to transplant.failure. V gamma 4 T (Vg4T) cells play an important role in mediating the immune response.in the early stage after transplantation; therefore, we wanted to verify whether suppressing.Vg4T cells by herpesvirus entry mediator (HVEM)/B and T lymphocyte attenuator (BTLA).signalling can promote MSCs osteogenesis in the transplanted area. In vitro experiments.showed that the osteogenic differentiation of MSCs and Vg4T cells was weakened after.co-culture, and an increase in interleukin-17 (IL-17) and interferon-g (IFN-g) levels was.detected in the culture supernatant. HVEM-transfected MSCs (MSCs-HVEM) still.exhibited osteogenic differentiation activity after co-culture with Vg4T cells, and the.levels of IL-17 and IFN-g in the co-culture supernatant were significantly reduced. In.vivo experiments revealed that inflammation in the transplanted area was reduced and.osteogenic repair was enhanced after Vg4T cells were removed. MSCs-HVEM can also.consistently contribute to reduced inflammation in the transplanted area and enhanced.bone repair in wild-type (WT) mice. Therefore, our experiments verified that HVEM can.promote the osteogenesis of allo-MSCs by inhibiting IL-17 and IFN-g secretion from.Vg4T cells.